Calamos Advisors’s Allergan Inc AGN Stock Holding History

Calamos Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-39,002	Closed	-$8.29M	–	764
2014 Q4	$8.29M	Buy	39,002 +202	+0.5%	+$40.2K	0.05%	288
2014 Q3	$6.91M	Sell	38,800 -500	-1%	-$83K	0.05%	300
2014 Q2	$6.65M	Buy	39,300 +3,300	+9%	+$514K	0.04%	305
2014 Q1	$4.47M	Sell	36,000 -64,447	-64%	-$7.85M	0.03%	326
2013 Q4	$11.2M	Buy	100,447 +64,447	+179%	+$6.16M	0.07%	233
2013 Q3	$3.26M	Hold	36,000	–	–	0.02%	346
2013 Q2	$3.03M	Buy	+36,000	New	+$3.73M	0.02%	353

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Calamos Advisors's AGN Position: Q1 2015 in Review

Calamos Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 39,002 shares — an estimated $8.29M sold.

Calamos Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $11.2M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Calamos Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Calamos Advisors sold 39,002 Allergan Inc shares in Q1 2015, an estimated $8.29M.
Calamos Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Calamos Advisors's Allergan Inc position peaked at $11.2M in Q4 2013.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Calamos Advisors's 13F filing for Q1 2015, filed 13 May 2015.